|
시장보고서
상품코드
2019576
유전체학 맞춤형 건강 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)Global Genomics Personalized Health Market Size, Share, Trends & Growth Analysis Report 2026-2034 |
||||||
유전체학 맞춤형 건강 시장 규모는 2025년 121억 3,000만 달러에서 2026년부터 2034년까지 CAGR 12.67%로 성장하여 2034년에는 355억 1,000만 달러에 달할 것으로 예측됩니다.
세계 유전체학 맞춤형 건강 시장은 정밀의료의 보급 확대와 유전자 조사의 발전으로 급속한 성장을 거듭하고 있습니다. 맞춤형 건강 솔루션은 유전체 정보를 활용하여 맞춤형 치료법 및 예방 전략을 수립합니다. 만성질환의 유병률 증가와 표적 치료제에 대한 수요 증가가 시장 확대를 이끄는 주요 요인으로 작용하고 있습니다. 또한, 염기서열 분석 기술의 발전으로 보다 정확하고 저렴한 가격으로 유전체 분석이 가능해졌습니다.
주요 성장 요인으로는 유전체 연구에 대한 투자 확대와 헬스케어 분야에서의 유전자 검사 이용 증가를 꼽을 수 있습니다. 소비자 대상 유전자 검사 서비스의 확대도 시장 성장에 기여하고 있습니다. 또한, 인공지능(AI)과 빅데이터 분석의 통합으로 유전체 데이터의 해석 정확도가 향상되고 있습니다. 예방 의료와 질병 조기 발견에 대한 관심이 높아지면서 맞춤형 건강 솔루션의 도입이 증가하고 있습니다.
향후 생명공학 및 데이터 분석의 지속적인 발전과 함께 유전체학에 기반한 맞춤형 의료 시장은 크게 성장할 것으로 예상됩니다. 보다 정확하고 이용하기 쉬운 유전체 분석 도구의 개발이 더욱 보급을 촉진할 것입니다. 신흥시장에서는 헬스케어 분야에 대한 투자가 증가함에 따라 강력한 성장 기회가 기대되고 있습니다. 또한, 지속적인 연구개발을 통해 헬스케어 분야에서의 유전체학의 적용 범위는 더욱 확대될 것입니다.
목차
제1장 소개
제2장 주요 요약
제3장 시장 변수, 동향, 프레임워크
제4장 세계의 유전체학 맞춤형 건강 시장 : 기술별
제5장 세계의 유전체학 맞춤형 건강 시장 : 테스트 유형별
제6장 세계의 유전체학 맞춤형 건강 시장 : 최종사용자별
제7장 세계의 유전체학 맞춤형 건강 시장 : 지역별
제8장 경쟁 구도
제9장 기업 개요
KSM 26.05.08The Genomics Personalized Health Market size is expected to reach USD 35.51 Billion in 2034 from USD 12.13 Billion (2025) growing at a CAGR of 12.67% during 2026-2034.
The global genomics personalized health market is witnessing rapid growth due to increasing adoption of precision medicine and advancements in genetic research. Personalized health solutions use genomic information to tailor treatments and preventive strategies for individuals. The rising prevalence of chronic diseases and the growing demand for targeted therapies are key factors driving market expansion. Additionally, advancements in sequencing technologies are enabling more accurate and affordable genomic analysis.
Key growth drivers include increasing investments in genomics research and the growing use of genetic testing in healthcare. The expansion of direct-to-consumer genetic testing services is also contributing to market growth. Furthermore, the integration of artificial intelligence and big data analytics is enhancing the interpretation of genomic data. The rising focus on preventive healthcare and early disease detection is supporting the adoption of personalized health solutions.
In the future, the genomics personalized health market is expected to grow significantly with continuous advancements in biotechnology and data analytics. The development of more precise and accessible genomic tools will further drive adoption. Emerging markets are likely to offer strong growth opportunities due to increasing healthcare investments. Additionally, ongoing research and innovation will expand the applications of genomics in healthcare.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
MARKET SEGMENTATION
By Technology
- NGS Platform
- RT-PCR
- Microarray
- Genetic Analyzer
- Others
By Test Type
- Oncology Testing
- Infectious Disease Testing
- Orphan Disease Testing
- Autoimmune Disease Testing
- Obstetrics Testing
- Others
By End-user
- Academics & Research Institutes
- Diagnostic Centers
- Others
COMPANIES PROFILED
- QIAGEN, Illumina Inc, Thermo Fisher Scientific Inc, BioRad Laboratories Inc, HoffmannLa Roche AG, Lonza Group, Invitae Corp, Genetic Technologies Limited, Interleukin Genetics Inc, Eastern Biotech and Life Sciences, DNA Genotek Inc, uBiome Inc, XCode Life Sciences Private Limited
- We can customise the report as per your requirements.
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL GENOMICS PERSONALIZED HEALTH MARKET: BY TECHNOLOGY 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Technology
- 4.2. NGS Platform Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. RT-PCR Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.4. Microarray Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.5. Genetic Analyzer Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL GENOMICS PERSONALIZED HEALTH MARKET: BY TEST TYPE 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Test Type
- 5.2. Oncology Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Infectious Disease Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.4. Orphan Disease Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.5. Autoimmune Disease Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.6. Obstetrics Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL GENOMICS PERSONALIZED HEALTH MARKET: BY END-USER 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast End-user
- 6.2. Academics & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL GENOMICS PERSONALIZED HEALTH MARKET: BY REGION 2022-2034 (USD MN)
- 7.1. Regional Outlook
- 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.2.1 By Technology
- 7.2.2 By Test Type
- 7.2.3 By End-user
- 7.2.4 United States
- 7.2.5 Canada
- 7.2.6 Mexico
- 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.3.1 By Technology
- 7.3.2 By Test Type
- 7.3.3 By End-user
- 7.3.4 United Kingdom
- 7.3.5 France
- 7.3.6 Germany
- 7.3.7 Italy
- 7.3.8 Russia
- 7.3.9 Rest Of Europe
- 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.4.1 By Technology
- 7.4.2 By Test Type
- 7.4.3 By End-user
- 7.4.4 India
- 7.4.5 Japan
- 7.4.6 South Korea
- 7.4.7 Australia
- 7.4.8 South East Asia
- 7.4.9 Rest Of Asia Pacific
- 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.5.1 By Technology
- 7.5.2 By Test Type
- 7.5.3 By End-user
- 7.5.4 Brazil
- 7.5.5 Argentina
- 7.5.6 Peru
- 7.5.7 Chile
- 7.5.8 Rest of Latin America
- 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.6.1 By Technology
- 7.6.2 By Test Type
- 7.6.3 By End-user
- 7.6.4 Saudi Arabia
- 7.6.5 UAE
- 7.6.6 Israel
- 7.6.7 South Africa
- 7.6.8 Rest of the Middle East And Africa
Chapter 8. COMPETITIVE LANDSCAPE
- 8.1. Recent Developments
- 8.2. Company Categorization
- 8.3. Supply Chain & Channel Partners (based on availability)
- 8.4. Market Share & Positioning Analysis (based on availability)
- 8.5. Vendor Landscape (based on availability)
- 8.6. Strategy Mapping
Chapter 9. COMPANY PROFILES OF GLOBAL GENOMICS PERSONALIZED HEALTH INDUSTRY
- 9.1. Top Companies Market Share Analysis
- 9.2. Company Profiles
- 9.2.1 QIAGEN
- 9.2.2 Illumina Inc
- 9.2.3 Thermo Fisher Scientific Inc
- 9.2.4 Bio-Rad Laboratories Inc
- 9.2.5 Hoffmann-La Roche AG
- 9.2.6 Lonza Group
- 9.2.7 Invitae Corp
- 9.2.8 Genetic Technologies Limited
- 9.2.9 Interleukin Genetics Inc
- 9.2.10 Eastern Biotech And Life Sciences
- 9.2.11 DNA Genotek Inc
- 9.2.12 UBiome Inc
- 9.2.13 XCode Life Sciences Private Limited
